Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 1 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Status: Completed Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20071
20082
20103
20111
20121
20133
20151
20162
20182
20192
20205
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Eli Lilly and Company5
Medtronic MiniMed, Inc.2
Second Xiangya Hospital of Central South University2
BIOTRONIK Asia Pacific Pte Ltd1
Bayer1
European Foundation for the Study of Diabetes1
Fuzhou General Hospital1
Huashan Hospital1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 131
Diabetes Mellitus, Type 211
Diabetes Mellitus10
Autoimmune Diseases2
Angina Pectoris1
Coronary Artery Disease1
Endocrine System Diseases1
Glucose Metabolism Disorders1
Immune System Diseases1
Insulin Resistance1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.